Irish Life Investment Managers’s Vertex Pharmaceuticals VRTX Stock Holding History

Irish Life Investment Managers’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$7.12M	Buy	+89,101	New	+$6.56M	0.09%	238

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Irish Life Investment Managers's VRTX Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2013: 89,101 shares worth $7.12M. The stake represents 0.09% of the portfolio and ranks #238 among its holdings.

376 funds tracked by Wall St. Rank hold VRTX as of Q2 2013.

Irish Life Investment Managers held 89,101 shares of Vertex Pharmaceuticals worth $7.12M as of Q2 2013.
Vertex Pharmaceuticals was a new Irish Life Investment Managers position in Q2 2013.
Vertex Pharmaceuticals made up 0.09% of Irish Life Investment Managers's portfolio in Q2 2013, its #238 holding.
376 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.